{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:43:27Z","timestamp":1790109807716,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL70283"],"award-info":[{"award-number":["R01-HL70283"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Aging","award":["R01AG031083"],"award-info":[{"award-number":["R01AG031083"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s11239-015-1301-8","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T04:50:33Z","timestamp":1454647833000},"page":"525-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based\u00a0Worcester Venous Thromboembolism Study"],"prefix":"10.1007","volume":"41","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"1301_CR1","volume-title":"Hemostasis and thrombosis basic principles and clinical practice","author":"RW Colman","year":"2006","unstructured":"Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ (2006) Hemostasis and thrombosis basic principles and clinical practice, vol 1, 5th edn. Lippincott Williams & Wilkins, Philadelphia","edition":"5"},{"issue":"2","key":"1301_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/ajh.21917","volume":"86","author":"SB Deitelzweig","year":"2011","unstructured":"Deitelzweig SB, Johnson BH, Lin J, Schulman KL (2011) Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol 86(2):217\u2013220","journal-title":"Am J Hematol"},{"issue":"8","key":"1301_CR3","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1111\/j.1538-7836.2005.01415.x","volume":"3","author":"JA Heit","year":"2005","unstructured":"Heit JA (2005) Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 3(8):1611\u20131617","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1301_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1378\/chest.08-2258","volume":"136","author":"B Park","year":"2009","unstructured":"Park B, Messina L, Dargon P, Huang W, Ciocca R, Anderson FA (2009) Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. Chest 136(4):983\u2013990","journal-title":"Chest"},{"key":"1301_CR5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.amjmed.2014.03.041","volume":"127","author":"W Huang","year":"2014","unstructured":"Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA (2014) Secular trends in occurrence of acute venous thromboembolism: the Worcester venous thromboembolism study (1985 to 2009). Am J Med 127:829\u2013839","journal-title":"Am J Med"},{"issue":"2 Suppl","key":"1301_CR6","doi-asserted-by":"publisher","first-page":"48S","DOI":"10.1378\/chest.11-2286","volume":"141","author":"GH Guyatt","year":"2012","unstructured":"Guyatt GH, Akl EA, Crowther M, Schunemann HJ, Gutterman DD, Zelman Lewis S (2012) Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):48S\u201352S","journal-title":"Chest"},{"issue":"1","key":"1301_CR7","first-page":"452","volume":"86","author":"JA Heit","year":"2001","unstructured":"Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O\u2019Fallon WM, Melton LJ III (2001) The epidemiology of venous thromboembolism in the community. Thromb Haemost 86(1):452\u2013463","journal-title":"Thromb Haemost"},{"issue":"4","key":"1301_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archinternmed.2007.69","volume":"168","author":"FA Spencer","year":"2008","unstructured":"Spencer FA, Gore JM, Lessard D, Douketis JD, Emery C, Goldberg RJ (2008) Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med 168(4):425\u2013430","journal-title":"Arch Intern Med"},{"issue":"23 Suppl 1","key":"1301_CR9","first-page":"I4","volume":"107","author":"RH White","year":"2003","unstructured":"White RH (2003) The epidemiology of venous thromboembolism. Circulation 107(23 Suppl 1):I4\u2013I8","journal-title":"Circulation"},{"issue":"6","key":"1301_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archinte.160.6.761","volume":"160","author":"JA Heit","year":"2000","unstructured":"Heit JA, Mohr DN, Silverstein MD, Petterson TM, O\u2019Fallon WM, Melton LJ III (2000) Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 160(6):761\u2013768","journal-title":"Arch Intern Med"},{"issue":"2","key":"1301_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3324\/haematol.10516","volume":"92","author":"P Prandoni","year":"2007","unstructured":"Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A (2007) The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 92(2):199\u2013205","journal-title":"Haematologica"},{"issue":"9","key":"1301_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","volume":"152","author":"M Carrier","year":"2010","unstructured":"Carrier M, Le Gal G, Wells PS, Rodger MA (2010) Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 152(9):578\u2013589","journal-title":"Ann Intern Med"},{"key":"1301_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1182\/asheducation-2013.1.471","volume":"2013","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Becattini C (2013) Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism. Am Soc Hematol Educ Progr 2013:471\u2013477","journal-title":"Am Soc Hematol Educ Progr"},{"issue":"14","key":"1301_CR14","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","volume":"121","author":"S Eichinger","year":"2010","unstructured":"Eichinger S, Heinze G, Jandeck LM, Kyrle PA (2010) Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation 121(14):1630\u20131636","journal-title":"Circulation"},{"issue":"4","key":"1301_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.111.051920","volume":"126","author":"ML Louzada","year":"2012","unstructured":"Louzada ML, Carrier M, Lazo-Langner A, Dao V, Kovacs MJ, Ramsay TO, Rodger MA, Zhang J, Lee AY, Meyer G, Wells PS (2012) Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. Circulation 126(4):448\u2013454","journal-title":"Circulation"},{"issue":"2","key":"1301_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1160\/TH13-09-0793","volume":"112","author":"C Martinez","year":"2014","unstructured":"Martinez C, Cohen AT, Bamber L, Rietbrock S (2014) Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer. Thromb Haemost 112(2):255\u2013263","journal-title":"Thromb Haemost"},{"issue":"10","key":"1301_CR17","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100(10):3484\u20133488","journal-title":"Blood"},{"issue":"5","key":"1301_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1503\/cmaj.080493","volume":"179","author":"MA Rodger","year":"2008","unstructured":"Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Solymoss S, Crowther M, Perrier A, White R, Vickars L, Ramsay T, Betancourt MT, Kovacs MJ (2008) Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 179(5):417\u2013426","journal-title":"CMAJ"},{"issue":"6","key":"1301_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","volume":"10","author":"A Tosetto","year":"2012","unstructured":"Tosetto A, Iorio A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Douketis J (2012) Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 10(6):1019\u20131025","journal-title":"J Thromb Haemost"},{"issue":"7","key":"1301_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1525-1497.2006.00458.x","volume":"21","author":"FA Spencer","year":"2006","unstructured":"Spencer FA, Emery C, Lessard D, Anderson F, Emani S, Aragam J, Becker RC, Goldberg RJ (2006) The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 21(7):722\u2013727","journal-title":"J Gen Intern Med"},{"issue":"14","key":"1301_CR21","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/archinte.167.14.1471","volume":"167","author":"FA Spencer","year":"2007","unstructured":"Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ (2007) Venous thromboembolism in the outpatient setting. Arch Intern Med 167(14):1471\u20131475","journal-title":"Arch Intern Med"},{"issue":"5","key":"1301_CR22","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","volume":"151","author":"FA Anderson Jr","year":"1991","unstructured":"Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151(5):933\u2013938","journal-title":"Arch Intern Med"},{"issue":"19","key":"1301_CR23","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","volume":"293","author":"SC Christiansen","year":"2005","unstructured":"Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293(19):2352\u20132361","journal-title":"JAMA"},{"issue":"12","key":"1301_CR24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJM199903253401201","volume":"340","author":"C Kearon","year":"1999","unstructured":"Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 340(12):901\u2013907","journal-title":"N Engl J Med"},{"issue":"3","key":"1301_CR25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1160\/TH09-10-0685","volume":"104","author":"G Le Gal","year":"2010","unstructured":"Le Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, Anderson DA, Chagnon I, Solymoss S, Crowther M, Righini M, Lacut K, White RH, Vickars L, Rodger M (2010) Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thromb Haemost 104(3):498\u2013503","journal-title":"Thromb Haemost"},{"issue":"3","key":"1301_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1056\/NEJM200107193450302","volume":"345","author":"G Agnelli","year":"2001","unstructured":"Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W, Warfarin Optimal Duration Italian Trial Investigators (2001) Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. N Engl J Med 345(3):165\u2013169","journal-title":"N Engl J Med"},{"issue":"6","key":"1301_CR27","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1538-7836.2009.03351.x","volume":"7","author":"AC Spyropoulos","year":"2009","unstructured":"Spyropoulos AC (2009) Upper vs. lower extremity deep vein thrombosis: outcome definitions of venous thromboembolism for clinical predictor rules or risk factor analyses in hospitalized patients. J Thromb Haemost 7(6):1041\u20131042","journal-title":"J Thromb Haemost"},{"issue":"8","key":"1301_CR28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.amjmed.2006.06.046","volume":"120","author":"FA Spencer","year":"2007","unstructured":"Spencer FA, Emery C, Lessard D, Goldberg RJ (2007) Upper extremity deep vein thrombosis: a community-based perspective. Am J Med 120(8):678\u2013684","journal-title":"Am J Med"},{"issue":"3","key":"1301_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2307\/2986270","volume":"43","author":"P Royston","year":"1994","unstructured":"Royston P, Altman D (1994) Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Appl Stat 43(3):429\u2013467","journal-title":"Appl Stat"},{"key":"1301_CR30","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1002\/ajh.23128","volume":"87","author":"JA Heit","year":"2012","unstructured":"Heit JA (2012) Predicting the risk of venous thromboembolism recurrence. Am J Hematol 87:S63\u2013S67","journal-title":"Am J Hematol"},{"key":"1301_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/9780470258019","volume-title":"Applied Survival Analysis","author":"DW Hosmer","year":"2008","unstructured":"Hosmer DW, Lemeshow S, May S (2008) Applied Survival Analysis, 2nd edn. Wiley, Hoboken, NJ","edition":"2"},{"issue":"18","key":"1301_CR32","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell Jr","year":"1982","unstructured":"Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247(18):2543\u20132546","journal-title":"JAMA"},{"issue":"3","key":"1301_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1023\/B:LIDA.0000036393.29224.1d","volume":"10","author":"S May","year":"2004","unstructured":"May S, Hosmer DW (2004) A cautionary note on the use of the Gronnesby and Borgan goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal 10(3):283\u2013291","journal-title":"Lifetime Data Anal"},{"issue":"3","key":"1301_CR34","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1378\/chest.10-1944","volume":"140","author":"AC Spyropoulos","year":"2011","unstructured":"Spyropoulos AC, Anderson FA Jr, Fitzgerald G, Decousus H, Pini M, Chong BH, Zotz RB, Bergmann JF, Tapson V, Froehlich JB, Monreal M, Merli GJ, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA (2011) Predictive and associative models to identify hospitalized medical patients at risk for venous thromboembolism. Chest 140(3):706\u2013714","journal-title":"Chest"},{"issue":"7578","key":"1301_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","volume":"333","author":"KA Fox","year":"2006","unstructured":"Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Werf F, Avezum A, Goodman SG, Flather MD, Anderson FA, Granger CB (2006) Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333(7578):1091","journal-title":"BMJ"},{"issue":"22","key":"1301_CR36","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","volume":"291","author":"KA Eagle","year":"2004","unstructured":"Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA (2004) A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291(22):2727\u20132733","journal-title":"JAMA"},{"issue":"19","key":"1301_CR37","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","volume":"163","author":"CB Granger","year":"2003","unstructured":"Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA (2003) Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163(19):2345\u20132353","journal-title":"Arch Intern Med"},{"issue":"1","key":"1301_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11239-012-0780-0","volume":"35","author":"W Huang","year":"2013","unstructured":"Huang W, Anderson FA, Spencer FA, Gallus A, Goldberg RJ (2013) Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review. J Thromb Thrombolysis 35(1):67\u201380","journal-title":"J Thromb Thrombolysis"},{"issue":"7655","key":"1301_CR39","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","volume":"336","author":"M Canonico","year":"2008","unstructured":"Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 336(7655):1227\u20131231","journal-title":"BMJ"},{"issue":"6","key":"1301_CR40","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.amjmed.2014.02.011","volume":"127","author":"FA Spencer","year":"2014","unstructured":"Spencer FA, Gurwitz JH, Schulman S, Linkins LA, Crowther MA, Ginsberg JS, Lee AY, Saczynski JS, Anand S, Lessard D, Emery C, Huang W, Goldberg RJ (2014) Venous thromboembolism in older adults: a community-based study. Am J Med 127(6):530\u2013537","journal-title":"Am J Med"},{"issue":"22","key":"1301_CR41","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1001\/archinte.160.22.3431","volume":"160","author":"JD Douketis","year":"2000","unstructured":"Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS (2000) Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3\u00a0months of anticoagulant therapy. Arch Intern Med 160(22):3431\u20133436","journal-title":"Arch Intern Med"},{"issue":"18","key":"1301_CR42","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1182\/blood-2011-05-357343","volume":"118","author":"JA Heit","year":"2011","unstructured":"Heit JA, Lahr BD, Petterson TM, Bailey KR, Ashrani AA, Melton LJ III (2011) Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood 118(18):4992\u20134999","journal-title":"Blood"},{"key":"1301_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.thromres.2015.06.030","volume":"136","author":"JA Heit","year":"2015","unstructured":"Heit JA, Lahr BD, Ashrani AA, Petterson TM, Bailey KR (2015) Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study. Thromb Res 136:298\u2013307","journal-title":"Thromb Res"},{"issue":"9","key":"1301_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/archinternmed.2011.178","volume":"171","author":"RS Wiener","year":"2011","unstructured":"Wiener RS, Schwartz LM, Woloshin S (2011) Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 171(9):831\u2013837","journal-title":"Arch Intern Med"},{"issue":"23 Suppl 1","key":"1301_CR45","first-page":"I9","volume":"107","author":"FA Anderson Jr","year":"2003","unstructured":"Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I9\u2013I16","journal-title":"Circulation"},{"issue":"16","key":"1301_CR46","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1001\/archinternmed.2010.272","volume":"170","author":"FA Spencer","year":"2010","unstructured":"Spencer FA, Bates SM, Goldberg RJ, Lessard D, Emery C, Glushchenko A, Gore JM, White RH (2010) A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med 170(16):1456\u20131462","journal-title":"Arch Intern Med"},{"issue":"9383","key":"1301_CR47","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","volume":"362","author":"T Baglin","year":"2003","unstructured":"Baglin T, Luddington R, Brown K, Baglin C (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 362(9383):523\u2013526","journal-title":"Lancet"},{"issue":"6","key":"1301_CR48","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/archinte.158.6.585","volume":"158","author":"MD Silverstein","year":"1998","unstructured":"Silverstein MD, Heit JA, Mohr DN, Petterson TM, O\u2019Fallon WM, Melton LJ III (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158(6):585\u2013593","journal-title":"Arch Intern Med"},{"issue":"9","key":"1301_CR49","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/archinte.158.9.1005","volume":"158","author":"RH White","year":"1998","unstructured":"White RH, Zhou H, Romano PS (1998) Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism. Arch Intern Med 158(9):1005\u20131010","journal-title":"Arch Intern Med"},{"issue":"3","key":"1301_CR50","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.thromres.2012.04.003","volume":"130","author":"M Verso","year":"2012","unstructured":"Verso M, Agnelli G, Ageno W, Imberti D, Moia M, Palareti G, Pistelli R, Cantone V (2012) Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry. Thromb Res 130(3):369\u2013373","journal-title":"Thromb Res"},{"issue":"5","key":"1301_CR51","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/MCP.0b013e328363ed7c","volume":"19","author":"D Poli","year":"2013","unstructured":"Poli D, Palareti G (2013) Assessing recurrence risk following acute venous thromboembolism: use of algorithms. Curr Opin Pulm Med 19(5):407\u2013412","journal-title":"Curr Opin Pulm Med"},{"key":"1301_CR52","doi-asserted-by":"publisher","first-page":"b605","DOI":"10.1136\/bmj.b605","volume":"338","author":"DG Altman","year":"2009","unstructured":"Altman DG, Vergouwe Y, Royston P, Moons KG (2009) Prognosis and prognostic research: validating a prognostic model. BMJ 338:b605","journal-title":"BMJ"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-015-1301-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1301-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:56:42Z","timestamp":1589702202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-015-1301-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1007\/s11239-015-1301-8","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]},"assertion":[{"value":"5 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Professor Anderson received research grants from Sanofi and The Medicines Company; he has served as a consultant to GlaxoSmithKline and Takeda Oncology on the design of outcomes studies. Dr. Cohen reports grants and personal fees from Bayer, Boehringer-Ingelheim, BMS, Daiichi, GSK, Johnson and Johnson, Pfizer, Portola, Sanofi and XO1, outside the submitted work. All other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}